ESTUTC-5 New YorkLog in Sign up

TLSA
Tiziana Life Sciences Ltd. Common Shares
stockNASDAQ

At CloseNov 6, 2026 3:59:21 PM EST

0.69USD+12.024%(+0.07)333,627

Pre-marketNov 6, 2026 9:26:30 AM EST

0.6357USD+2.466%(+0.0153)

After-hoursNov 6, 2026 4:02:30 PM EST

0.6888USD-0.892%(-0.0062)

TLSA News

Day breaks

02:00 PM ESTTiziana to Host Investor Call with Key Opinion Leaders to Discuss Positive Phase 2a INFORM-MS Topline Results ·

GlobeNewswire Inc.

05:02 AM ESTTiziana’s Phase IIa trial of foralumab meets dual endpoints in na-SPMS ·

Clinical Trials Arena

04:01 PM ESTTiziana Life Sciences (TLSA) Shares Drop 13% Despite Positive Phase 2a Trial Results ·

GuruFocus

03:13 PM ESTTiziana falters following mid-stage results for multiple sclerosis asset ·

Seeking Alpha

07:00 AM EDTTiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease ·

GlobeNewswire Inc.

07:36 AM EDTTiziana Files For Orphan Drug Designation For Foralumab In MSA ·

RTTNews

07:00 AM EDTTiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab ·

GlobeNewswire Inc.

07:00 AM EDTTiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab ·

GlobeNewswire Inc.

08:33 AM EDTTiziana Life Sciences stock jumps on MS trial partnership ·

Investing.com

07:00 AM EDTTiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center ·

GlobeNewswire Inc.